{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.document_loaders.csv_loader import CSVLoader\n",
    "from langchain_community.document_loaders.merge import MergedDataLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
    "\n",
    "from transformers import AutoTokenizer, AutoModel\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "58850\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(page_content='Abstract: SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'}),\n",
       " Document(page_content='Abstract: Acute inflammation is a severe medical condition defined as an inflammatory response of the body to an infection Its rapid progression requires quick and accurate decisions from clinicians Inadequate and delayed decisions makes acute inflammation the 10th leading cause of death overall in United States with the estimated cost of treatment about 17 billion annually However despite the need there are limited number of methods that could assist clinicians to determine optimal therapies for acute inflammation We developed a datadriven method for suggesting optimal therapy by using machine learning model that is learned on historical patients behaviors To reduce both the risk of failure and the expense for clinical trials our method is evaluated on a virtual patients generated by a mathematical model that emulates inflammatory response In conducted experiments acute inflammation was handled with two complimentary pro and antiinflammatory medications which adequate timing and doses are crucial for the successful outcome Our experiments show that the dosage regimen assigned with our datadriven method significantly improves the percentage of healthy patients when compared to results by other methods used in clinical practice and found in literature Our method saved 88 of patients that would otherwise die within a week while the best method found in literature saved only 73 of patients At the same time our method used lower doses of medications than alternatives In addition our method achieved better results than alternatives when only incomplete or noisy measurements were available over time as well as it was less affected by therapy delay The presented results provide strong evidence that models from the artificial intelligence community have a potential for development of personalized treatment strategies for acute inflammation', metadata={'source': 'Acute inflammation is a severe medical condition defined as an inflammatory response of the body to an infection Its rapid progression requires quick and accurate decisions from clinicians Inadequate and delayed decisions makes acute inflammation the 10th leading cause of death overall in United States with the estimated cost of treatment about 17 billion annually However despite the need there are limited number of methods that could assist clinicians to determine optimal therapies for acute inflammation We developed a datadriven method for suggesting optimal therapy by using machine learning model that is learned on historical patients behaviors To reduce both the risk of failure and the expense for clinical trials our method is evaluated on a virtual patients generated by a mathematical model that emulates inflammatory response In conducted experiments acute inflammation was handled with two complimentary pro and antiinflammatory medications which adequate timing and doses are crucial for the successful outcome Our experiments show that the dosage regimen assigned with our datadriven method significantly improves the percentage of healthy patients when compared to results by other methods used in clinical practice and found in literature Our method saved 88 of patients that would otherwise die within a week while the best method found in literature saved only 73 of patients At the same time our method used lower doses of medications than alternatives In addition our method achieved better results than alternatives when only incomplete or noisy measurements were available over time as well as it was less affected by therapy delay The presented results provide strong evidence that models from the artificial intelligence community have a potential for development of personalized treatment strategies for acute inflammation', 'row': 1, 'PMID': '24565439', 'Title': 'A data-driven acute inflammation therapy.', 'Authors': 'Vladan Radosavljevic Kosta Ristovski Zoran Obradovic', 'Publication Date': '2013', 'DOI': '10.1186/1755-8794-6-S3-S7'})]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "loader_1 = CSVLoader(\n",
    "    file_path='../data/processed_data_part1.csv', \n",
    "    source_column='Abstract',\n",
    "    metadata_columns=['PMID', 'Title', 'Authors', 'Publication Date', 'DOI'])\n",
    "\n",
    "loader_2 = CSVLoader(\n",
    "    file_path='../data/processed_data_part2.csv', \n",
    "    source_column='Abstract',\n",
    "    metadata_columns=['PMID', 'Title', 'Authors', 'Publication Date', 'DOI'])\n",
    "\n",
    "loader_all = MergedDataLoader(loaders=[loader_1, loader_2])\n",
    "docs_all = loader_all.load()\n",
    "\n",
    "print(len(docs_all))\n",
    "docs_all[:2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Document(page_content='Abstract: SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'})"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Apply text splitting into chunks to prevent truncation of longer abstracts\n",
    "# Chunk size: since BERT's max token length is 512, a safe chunk size might be 200-300\n",
    "# Overlap size: to maintain context around 50-100 words\n",
    "\n",
    "text_splitter = RecursiveCharacterTextSplitter(chunk_size=250, \n",
    "                                               chunk_overlap=75,\n",
    "                                               length_function=len,\n",
    "                                               is_separator_regex=False,)\n",
    "docs = text_splitter.split_documents(docs_all)\n",
    "\n",
    "docs[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Try out SentenceTransformersTokenTextSplitter: \n",
    "# splits the text into chunks that fit the token window of the sentence transformer model\n",
    "\n",
    "# from langchain.text_splitter import SentenceTransformersTokenTextSplitter\n",
    "\n",
    "# splitter = SentenceTransformersTokenTextSplitter(chunk_overlap=0)\n",
    "\n",
    "# count_start_and_stop_tokens = 2\n",
    "# text = \"Lorem \"\n",
    "# text_token_count = splitter.count_tokens(text=text) - count_start_and_stop_tokens\n",
    "# print(text_token_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'list'>\n",
      "False\n",
      "[Document(page_content='Abstract: SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'}), Document(page_content='shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'}), Document(page_content='with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'}), Document(page_content='of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'}), Document(page_content='scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime', metadata={'source': 'SUMMARY Several lines of evidence support the involvement of inflammatory and immunologic abnormalities in chronic fatigue syndrome CFS Since recent studies have shown that α1 antitrypsin AAT possesses antiinflammatory properties the potential therapeutic effect of AAT treatment on CFS has been investigated A 49yearold woman diagnosed with CFS was treated with intravenous infusions of a human plasmaderived AAT concentrate 60 mgkg body weight weekly for 8 consecutive weeks The patients monocyte elastase a regulator of inflammatory processes was 1170 Umg At completion of treatment improvement in maximal workload was observed 540717 of predicted Additionally amelioration in working memory scores 8394 and perceptual organization scores 7583 were detected on the Wechsler Adult Intelligence ScaleIII test Monocyte elastase decreased to a normal range 150 Umg Improvement in functional capacity allowed the patient to work in parttime employment These findings suggest a possible role for AAT in the treatment of CFS', 'row': 0, 'PMID': '24645995', 'Title': 'α-1 antitrypsin and chronic fatigue syndrome: a case study from pathophysiology to clinical practice.', 'Authors': 'Jose Alegre Sandra Camprubi Ana GarciaQuintana', 'Publication Date': '2013-Mar', 'DOI': '10.2217/pmt.12.84'})]\n"
     ]
    }
   ],
   "source": [
    "print(type(docs))\n",
    "print(all(isinstance(doc, str) for doc in docs))\n",
    "print(docs[:5])  # Print the first few elements to check their format\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No sentence-transformers model found with name /Users/sandrafriebolin/.cache/torch/sentence_transformers/dmis-lab_biobert-base-cased-v1.1. Creating a new one with MEAN pooling.\n"
     ]
    }
   ],
   "source": [
    "# Generate embeddings using different embedding models\n",
    "\n",
    "#tokenizer = AutoTokenizer.from_pretrained(\"dmis-lab/biobert-base-cased-v1.1\")\n",
    "#model = AutoModel.from_pretrained(\"dmis-lab/biobert-base-cased-v1.1\")\n",
    "\n",
    "model_name = \"dmis-lab/biobert-base-cased-v1.1\"\n",
    "\n",
    "model_kwargs = {'device': 'cpu'}\n",
    "encode_kwargs = {'normalize_embeddings': False}\n",
    "embeddings = HuggingFaceEmbeddings(\n",
    "    model_name=model_name,\n",
    "    model_kwargs=model_kwargs,\n",
    "    encode_kwargs=encode_kwargs\n",
    ")\n",
    "\n",
    "docs_texts = [doc.page_content for doc in docs]\n",
    "document_embeddings = embeddings.embed_documents(texts=docs_texts)\n",
    "\n",
    "print(len(document_embeddings))\n",
    "print(len(document_embeddings[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert the list of arrays to a numpy array\n",
    "embeddings_array = np.array(embeddings)\n",
    "\n",
    "# Save the embeddings to a .npy file\n",
    "np.save(\"../embeddings/biobert_embeddings.npy\", embeddings_array)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "nlp-transformers",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
